Epsilon-aminocaproic acid for synovectomy in haemophilic patients

E. Storti, E. Ascari, R. Turpini, E. Molinari, G. Gamba, A. Pettene

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The study of coagulation and fibrinolysis in synovectomised haemophilic patients, treated by a new haemostatic combined therapy, is reported. This treatment is based on a combination of replacement therapy (fresh frozen plasma and/or cryoprecipitates) and ε-aminocaproic acid; the replacement therapy is continued for only 6 days, beginning on the day of operation. Our combined therapy scheme promotes a more efficient haemostasis than substitutive therapy alone and allows a considerable saving in plasma or plasma fractions.

Original languageEnglish
Pages (from-to)146-156
Number of pages11
JournalActa Haematologica
Volume47
Issue number3
DOIs
Publication statusPublished - 1972

Fingerprint

Aminocaproic Acid
Therapeutics
Fibrinolysis
Hemostatics
Hemostasis

Keywords

  • Haemophilia
  • Haemostasis
  • Joint surgery
  • Synovectomy
  • ε-Aminocaproic acid

ASJC Scopus subject areas

  • Hematology

Cite this

Storti, E., Ascari, E., Turpini, R., Molinari, E., Gamba, G., & Pettene, A. (1972). Epsilon-aminocaproic acid for synovectomy in haemophilic patients. Acta Haematologica, 47(3), 146-156. https://doi.org/10.1159/000208509

Epsilon-aminocaproic acid for synovectomy in haemophilic patients. / Storti, E.; Ascari, E.; Turpini, R.; Molinari, E.; Gamba, G.; Pettene, A.

In: Acta Haematologica, Vol. 47, No. 3, 1972, p. 146-156.

Research output: Contribution to journalArticle

Storti, E, Ascari, E, Turpini, R, Molinari, E, Gamba, G & Pettene, A 1972, 'Epsilon-aminocaproic acid for synovectomy in haemophilic patients', Acta Haematologica, vol. 47, no. 3, pp. 146-156. https://doi.org/10.1159/000208509
Storti E, Ascari E, Turpini R, Molinari E, Gamba G, Pettene A. Epsilon-aminocaproic acid for synovectomy in haemophilic patients. Acta Haematologica. 1972;47(3):146-156. https://doi.org/10.1159/000208509
Storti, E. ; Ascari, E. ; Turpini, R. ; Molinari, E. ; Gamba, G. ; Pettene, A. / Epsilon-aminocaproic acid for synovectomy in haemophilic patients. In: Acta Haematologica. 1972 ; Vol. 47, No. 3. pp. 146-156.
@article{747d88e47eac46b1b2f71fbde2ef2df2,
title = "Epsilon-aminocaproic acid for synovectomy in haemophilic patients",
abstract = "The study of coagulation and fibrinolysis in synovectomised haemophilic patients, treated by a new haemostatic combined therapy, is reported. This treatment is based on a combination of replacement therapy (fresh frozen plasma and/or cryoprecipitates) and ε-aminocaproic acid; the replacement therapy is continued for only 6 days, beginning on the day of operation. Our combined therapy scheme promotes a more efficient haemostasis than substitutive therapy alone and allows a considerable saving in plasma or plasma fractions.",
keywords = "Haemophilia, Haemostasis, Joint surgery, Synovectomy, ε-Aminocaproic acid",
author = "E. Storti and E. Ascari and R. Turpini and E. Molinari and G. Gamba and A. Pettene",
year = "1972",
doi = "10.1159/000208509",
language = "English",
volume = "47",
pages = "146--156",
journal = "Acta Haematologica",
issn = "0001-5792",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Epsilon-aminocaproic acid for synovectomy in haemophilic patients

AU - Storti, E.

AU - Ascari, E.

AU - Turpini, R.

AU - Molinari, E.

AU - Gamba, G.

AU - Pettene, A.

PY - 1972

Y1 - 1972

N2 - The study of coagulation and fibrinolysis in synovectomised haemophilic patients, treated by a new haemostatic combined therapy, is reported. This treatment is based on a combination of replacement therapy (fresh frozen plasma and/or cryoprecipitates) and ε-aminocaproic acid; the replacement therapy is continued for only 6 days, beginning on the day of operation. Our combined therapy scheme promotes a more efficient haemostasis than substitutive therapy alone and allows a considerable saving in plasma or plasma fractions.

AB - The study of coagulation and fibrinolysis in synovectomised haemophilic patients, treated by a new haemostatic combined therapy, is reported. This treatment is based on a combination of replacement therapy (fresh frozen plasma and/or cryoprecipitates) and ε-aminocaproic acid; the replacement therapy is continued for only 6 days, beginning on the day of operation. Our combined therapy scheme promotes a more efficient haemostasis than substitutive therapy alone and allows a considerable saving in plasma or plasma fractions.

KW - Haemophilia

KW - Haemostasis

KW - Joint surgery

KW - Synovectomy

KW - ε-Aminocaproic acid

UR - http://www.scopus.com/inward/record.url?scp=0015265298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015265298&partnerID=8YFLogxK

U2 - 10.1159/000208509

DO - 10.1159/000208509

M3 - Article

VL - 47

SP - 146

EP - 156

JO - Acta Haematologica

JF - Acta Haematologica

SN - 0001-5792

IS - 3

ER -